Today is the final day of GIANT Health Event, where DigitalHealth.London has been leading a fantastic three days packed full of NHS, industry and research speakers aimed at helping tech innovators to work with the NHS. They have also just launched an exciting new partnership with RYSE Asset Management and are looking for digital health start-ups that could benefit from their expertise and funding. Read further down for more information.
A lot has been happening politically this month too, with the vote for the European Medicines Agency to relocate to Amsterdam; the Budget announcement; and the Government’s Industrial Strategy which launched on Monday. It’s fantastic news that MSD is set to open a research facility in London, which could support up to 950 jobs, and the Government has shown its commitment to life sciences with a boost for R&D spending and funding to speed up the delivery of the Cambridge South railway station. Adaptimmune Therapeutics plc, a leader in T Cell therapy for cancers, also officially opened their HQ in Oxfordshire this month, bringing together their R&D operations and corporate teams at Milton Park.
I was on a panel this month looking at open innovation and the importance of geographical clusters at FT’s Annual Global Pharma and Biotech Conference. You can watch the session back here. In December, we’ll be speaking at the Milken Institute’s Annual Summit on transforming healthcare through tech; in Oxford at the Innovation Forum Leaders Conference discussing Diversity and Inclusion; at EIT Health Summit speaking about women entrepreneurs; and we have a breakfast briefing around UK-Japan opportunities at Genesis coming up too.
I also would like to welcome our new Angels in MedCity Manager, Joana Neves Dos Reis, to the team – you can get in touch with her at email@example.com
I hope to see you all at an event soon to toast the Christmas season!